| Computational analysis of microbial flow cytometry data P Rubbens, R Props MSystems 6 (1), 10.1128/msystems. 00895-20, 2021 | 22 | 2021 |
| Kidney development and perspectives for organ engineering G Reint, A Rak-Raszewska, SJ Vainio Cell and Tissue Research 369, 171-183, 2017 | 15 | 2017 |
| Rapid genome editing by CRISPR-Cas9-POLD3 fusion G Reint, Z Li, K Labun, S Keskitalo, I Soppa, K Mamia, E Tolo, ... Elife 10, e75415, 2021 | 12 | 2021 |
| Spontaneous formation and rearrangement of artificial lipid nanotube networks as a bottom-up model for endoplasmic reticulum ES Köksal, PF Belletati, G Reint, R Olsson, KD Leitl, I Kantarci, I Gözen JoVE (Journal of Visualized Experiments), e58923, 2019 | 8 | 2019 |
| Optimization of Cas12a for multiplexed genome-scale transcriptional activation AL Griffith, F Zheng, AV McGee, NW Miller, ZM Szegletes, G Reint, ... Cell Genomics 3 (9), 2023 | 5 | 2023 |
| Deciphering the minimal quantity of mouse primary cells to undergo nephrogenesis ex vivo A Rak‐Raszewska, G Reint, F Geiger, F Naillat, SJ Vainio Developmental Dynamics 251 (3), 536-550, 2022 | 3 | 2022 |
| Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq Z Li, G Reint, EM Haapaniemi STAR protocols 4 (4), 102662, 2023 | | 2023 |
| Improved gene editing E Haapaniemi, J Taipale, G Reint US Patent App. 18/020,720, 2023 | | 2023 |
| CRISPR-Cas9 T Cell Editing for Finnish Founder Diseases K Mamia, Z Li, G Reint, N Fatkhutdinov, F Haugen, T Gjerdingen, ... MOLECULAR THERAPY 30 (4), 455-455, 2022 | | 2022 |
| Rapid Genome Editing by Cas9-POLD3 Fusion G Reint, Z Li, K Labun, S Keskitalo, I Soppa, K Mamia, E Tolo, ... MOLECULAR THERAPY 30 (4), 267-267, 2022 | | 2022 |
